The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Dec. 09, 2014

Filed:

Jun. 22, 2010
Applicants:

Rajesh Jain, New Delhi, IN;

Sanjay Trehan, New Delhi, IN;

Jagattaran Das, New Delhi, IN;

Gurmeet Kaur, New Delhi, IN;

Sandeep Kanwar, New Delhi, IN;

Nishan Singh, New Delhi, IN;

Gurmeet Kaur Nanda, New Delhi, IN;

Sitaram Kumar Magadi, New Delhi, IN;

Sudhir Kumar Sharma, New Delhi, IN;

Inventors:

Rajesh Jain, New Delhi, IN;

Sanjay Trehan, New Delhi, IN;

Jagattaran Das, New Delhi, IN;

Gurmeet Kaur, New Delhi, IN;

Sandeep Kanwar, New Delhi, IN;

Nishan Singh, New Delhi, IN;

Gurmeet Kaur Nanda, New Delhi, IN;

Sitaram Kumar Magadi, New Delhi, IN;

Sudhir Kumar Sharma, New Delhi, IN;

Assignee:

Panacea Biotec Limited, New Delhi, IN;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/5355 (2006.01); C07D 413/10 (2006.01); C07D 209/52 (2006.01); C07D 417/14 (2006.01); C07D 491/08 (2006.01); C07D 221/22 (2006.01); C07D 487/04 (2006.01); C07D 413/14 (2006.01); C07D 409/04 (2006.01); C07D 471/04 (2006.01); C07D 417/10 (2006.01); C07D 401/10 (2006.01);
U.S. Cl.
CPC ...
C07D 221/22 (2013.01); C07D 209/52 (2013.01); C07D 417/14 (2013.01); C07D 491/08 (2013.01); C07D 487/04 (2013.01); C07D 413/14 (2013.01); C07D 409/04 (2013.01); C07D 471/04 (2013.01); C07D 417/10 (2013.01); C07D 413/10 (2013.01); C07D 401/10 (2013.01);
Abstract

The present invention relates to novel compounds of Formula I, their pharmaceutically acceptable derivatives, tautomeric forms, stereoisomers including R and S isomers, polymorphs, prodrugs, metabolites, salts or solvates thereof. The invention also relates to processes for the synthesis of novel compounds of Formula I, their pharmaceutically acceptable derivatives, tautomeric forms, stereoisomers, polymorphs, prodrugs, metabolites, salts or solvates thereof.


Find Patent Forward Citations

Loading…